AC Immune SA
ACIU
$1.66
-$0.11-6.22%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.99M | 6.36M | -25.17M | -20.43M | -5.36M |
| Total Depreciation and Amortization | 602.40K | 611.60K | 606.00K | 635.90K | 626.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.32M | -1.35M | 10.16M | 249.30K | 2.96M |
| Change in Net Operating Assets | 25.46M | -21.98M | 95.16M | 20.72M | -16.51M |
| Cash from Operations | 6.76M | -16.35M | 80.76M | 1.17M | -18.29M |
| Capital Expenditure | -102.50K | -195.40K | -75.20K | -284.80K | -187.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.25M | -2.22M | -83.77M | -26.66M | 26.48M |
| Cash from Investing | -4.36M | -2.41M | -83.84M | -26.95M | 26.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -171.00K | -172.00K | -173.00K | -167.00K | -139.00K |
| Issuance of Common Stock | -- | -- | 135.00K | 2.00K | 41.17M |
| Repurchase of Common Stock | -25.00K | -1.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.00K | 0.00 | -24.00K | -523.00K | -- |
| Cash from Financing | -224.30K | -200.00K | -68.60K | -786.90K | 46.33M |
| Foreign Exchange rate Adjustments | 2.22M | -3.17M | -2.87M | 1.99M | -1.75M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.39M | -22.14M | -6.02M | -24.57M | 52.59M |
